Navamedic is a Nordic pharmaceutical company dedicated to improving quality of life by providing reliable access to high‑quality prescription medicines, consumer health products, and hospital‑critical therapies. Our portfolio focuses on some of today’s most important public health challenges, including addiction, obesity, and Parkinson’s disease.

With deep local insight and strong commercial expertise, we tailor market strategies to the needs of each country we serve. This makes Navamedic a trusted partner for international companies seeking growth across the Nordic and Benelux regions or looking for unique products for their home markets.

Listed on the Oslo Stock Exchange since 2006 (ticker: NAVA). Navamedic operates from its headquarters in Oslo, Norway.